Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2010
03/04/2010US20100055109 Post-translationally modified neurotrophins
03/04/2010US20100055108 Drug for treating gastric cancer
03/04/2010US20100055107 Methods for preventing hematological malignancies and graft versus host disease by anti-cd3 preconditioning
03/04/2010US20100055106 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
03/04/2010US20100055105 Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof
03/04/2010US20100055104 Therapeutic composition comprising an inhibitor of an hsp 90 protein
03/04/2010US20100055103 Cross-reactive and bispecific anti-il-17a/f antibodies
03/04/2010US20100055102 Compositions of pd-1 antagonists and methods of use
03/04/2010US20100055101 Cytokine receptor zcytor17 multimers
03/04/2010US20100055100 Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
03/04/2010US20100055099 Diagnostics and Treatments for VEGF-Independent Tumors
03/04/2010US20100055098 Method for treating multiple sclerosis patients with anti-il2r antibodies
03/04/2010US20100055097 Stable lyophilized pharmaceutical formulation of igg antibodies
03/04/2010US20100055096 Methods and reagents for the analysis and purification of polysaccharides
03/04/2010US20100055095 Genetic variations associated with tumors
03/04/2010US20100055094 Pharmaceutical combinations of 1-cyclopropyl-3- [3-(5-m0rphoolin-4-yl-methyl-1h-benzoimidazol-2-yl)- lh-1-pyrazol-4-yl]- urea
03/04/2010US20100055093 Pan-cell surface receptor-specific therapeutics
03/04/2010US20100055092 Preventive or Remedy for Inflammatory Disease
03/04/2010US20100055091 Novel GL-50 Molecules and Uses Therefor
03/04/2010US20100055090 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
03/04/2010US20100055089 Methods for Inhibition of Lymphangiogenesis and Tumor Metastasis
03/04/2010US20100055088 CXCR4 Antagonists for Wound Healing and Re-Epithelialization
03/04/2010US20100055072 2-oxo-1,2-dihydro-quinoline modulators of immune function
03/04/2010US20100055034 Human Anti-Folate Receptor Alpha Antibodies and Antibody Fragments for the Radioimmunotherapy of Ovarian Carcinoma
03/04/2010US20100055033 Antibody compositions and methods for treatment of neoplastic disease
03/04/2010US20100055009 Treating chamber for high-strength pulse electric field and high-frequency electric field treating equipment
03/04/2010DE102008045127A1 Filtersystem zur extrakorporalen Abreicherung von aktivierten Polymorphkernigen Granuloyzten (Polymorphonuclear leukocytes-PMNs) Filter system for extracorporeal depletion of activated polymorphonuclear Granuloyzten (polymorphonuclear leukocytes PMNs)
03/04/2010CA2737761A1 Vaccine compositions
03/04/2010CA2735502A1 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
03/04/2010CA2735421A1 Delivery of a cd40 agonist to a tumor draining lymph node of a subject
03/04/2010CA2735279A1 Anti-cd5 antibodies
03/04/2010CA2735278A1 Hiv-1 envelope polypeptides for hiv vaccine
03/04/2010CA2735171A1 Prevention, treatment and diagnosis of p.gingivalis infection
03/04/2010CA2735169A1 Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
03/04/2010CA2735164A1 West nile virus vaccine
03/04/2010CA2735155A1 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases
03/04/2010CA2734950A1 Vaccine
03/04/2010CA2734779A1 Treatment of thrombocytopenia
03/04/2010CA2734390A1 Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
03/04/2010CA2732642A1 Cross-reactive and bispecific anti-il-17a/f antibodies
03/04/2010CA2732215A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies
03/04/2010CA2730909A1 Method for treating multiple sclerosis patients with anti-il2r antibodies
03/04/2010CA2697993A1 Methods of enhancing adjuvanticity of vaccine compositions
03/03/2010EP2159230A1 Anti-TNF antibodies, compositions, methods and uses
03/03/2010EP2158921A1 Intranasal influenza vaccine based on virosomes
03/03/2010EP2158920A1 Stabilizing alkylglycoside compositions and methods thereof
03/03/2010EP2158917A1 P.ariasi polypeptides, P.perniciosus polypeptides and methods of use
03/03/2010EP2158898A1 Stabilizing alkylglycoside compositions and method thereof
03/03/2010EP2158488A2 Mutated parvovirus structural proteins as vaccines
03/03/2010EP2158318A2 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
03/03/2010EP2158315A2 Methods of modifying antibodies, and modified antibodies with improved functional properties
03/03/2010EP2158222A1 Milk derived antigen specific antibodies, methods of preparation and uses thereof
03/03/2010EP2157980A2 Methods for the directed expansion of epitopes for use as antibody ligands
03/03/2010EP1756270B1 Diagnosis and treatment of myeloid and lymphoid cell cancers with chlorotoxin or a derivative
03/03/2010EP1743648B1 Method for treating inflammation
03/03/2010EP1651266B1 Administration of anti-tnf-alpha f(ab')2 antibody fragments
03/03/2010EP1419179B1 Antigen binding domains from fish
03/03/2010EP1286682B1 Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury
03/03/2010EP1162998B1 Vaccine against streptococcus pneumoniae capsular polysaccharides
03/03/2010EP0973381B1 Animal model for evaluation of vaccines
03/03/2010EP0859831B1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences
03/03/2010CN101663049A Cytotoxicity mediation of cells evidencing surface expression of CD44
03/03/2010CN101663048A methods and compositions for diagnosing ankylosing spondylitis using biomarkers
03/03/2010CN101658672A Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
03/03/2010CN101658671A Humanized single chain antibody of anti-hepatitis B virus surface antigen a determinant and application thereof
03/03/2010CN101658670A AIDS vaccine of N1L and B8R gene deletion-based vaccinia virus vector
03/03/2010CN101658669A Attenuated live vaccine
03/03/2010CN101658668A Method and application for preparing bacteria simulacrum by using antibacterial peptide
03/03/2010CN101658667A Cryptosporidium parvum divalent protein vaccine and preparation method thereof
03/02/2010USRE41158 Diagnostic probes
03/02/2010USRE41157 Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
03/02/2010US7671250 Mammal that has acquired immunological tolerance to a foreign DNA and/or its expression product; expresses a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes
03/02/2010US7671186 Multimeric hybrid genes encoding the chimeric protein; single recombinant immunogen capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV)
03/02/2010US7671022 administering molecules that block endogenous costimulatory (B7) interactions with cytotoxic t lymphocytes(CTLA4) and/or CD28 antigens
03/02/2010US7670855 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
03/02/2010US7670805 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments
03/02/2010US7670804 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; anticancer
03/02/2010US7670766 Early detection of flaviviruses using the NS1 glycoprotein
03/02/2010US7670764 Methods of diagnosing tissue fibrosis
03/02/2010US7670611 Cancer immunotherapy with semi-allogeneic cells
03/02/2010US7670610 Recombinant BCG vaccine
03/02/2010US7670609 Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
03/02/2010US7670608 Selection of patients with increased responsiveness to botulinum toxin
03/02/2010US7670607 Pharmaceutical compositions for treating papillomavirus tumors and infection
03/02/2010US7670606 Method for administering a vaginal care composition
03/02/2010US7670605 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/02/2010US7670604 Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
03/02/2010US7670603 Using toll-like receptor polypeptides to generate atibodies for use in treatment and prevention of septic shock, inflammation and viral infection
03/02/2010US7670602 Concatameric immunoadhesion molecule
03/02/2010US7670601 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders
03/02/2010US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab
03/02/2010US7670599 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy
03/02/2010US7670597 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
03/02/2010US7670595 Fc-interferon-beta fusion proteins
03/02/2010CA2390659C Ny-eso-1 peptide derivatives, and uses thereof
03/02/2010CA2190359C Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
02/2010
02/25/2010WO2010022398A1 Diagnosis and treatment of neuro-inflammatory disorders
02/25/2010WO2010022341A1 Methods of enriching and using regulatory t cells
02/25/2010WO2010022293A2 Methods of processing compositions containing microparticles
02/25/2010WO2010022279A1 Antibodies and related molecules that bind to 58p1d12 proteins
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 1823